Lewy bodies and olfactory dysfunction in old age

Chemical Senses

Volumn 36, Issue 4, 2011, Pages 367-373

  Wilson, Robert S ^a,b   Yu, Lei ^a,b   Schneider, Julie A ^a,b   Arnold, Steven E ^c   Buchman, Aron S ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Lewy body disease; Odor identification; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ARTICLE; AUTOPSY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LEWY BODY; LIMBIC CORTEX; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NIGRAL CELL LOSS; OLFACTORY DISCRIMINATION; PARKINSONISM; PRIORITY JOURNAL; SENESCENCE; SENILE PLAQUE; SMELLING DISORDER; SUBSTANTIA NIGRA;

EID: 79954590116     PISSN: 0379864X     EISSN: 14643553     Source Type: Journal    
DOI: 10.1093/chemse/bjq139     Document Type: Article

References (46)

1. Ansari KA, Johnson A. 1975. Olfactory function in patients with Parkinson's disease. J Chronic Dis. 33:943-946.
2. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, et al. 2009. Unified staging for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117:613-634.
3. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, et al. 2006. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two communitybased cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiol. 27:169-176.
4. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. 2006. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 66: 1837-1844.
5. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon CF, Bienias JL, Wilson RS. 2005. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiol. 25: 163-175.
6. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. 2005. Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions. Neurology. 64:834-841.
7. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. 1997. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 49:1580-1587.
8. Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL. 2003. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 60:1909-1915.
9. Boyle PA, Wilson RS, Aggarwal NT, Tang Y, Bennett DA. 2006. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 67:441-445.
10. Braak H, del Tredici K, Rub U, de Vos RAI, Jansen Steur ENH, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 24:197-211.
11. Calhoun-Haney R, Murphy C. 2005. Apolipoprotein e4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn. 58:178-182.
12. DelleDonne A, Klox KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Utti RJ, et al. 2008. Incident Lewy body disease and preclinical Parkinson disease. Arch Neurol. 65: 1074-1080.
13. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon NJ, Doty RL, Stern Y, Pelton GH. 2008. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 64:871-879.
14. Doty RL, Deems DA, Stellar S. 1988. Olfactory function in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 38:1237-1238.
15. Doty RL, Frye RE, Agrawal U. 1989. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 45:381-384.
16. Doty RL, Marcus A, Lee WW. 1996. Development of the 12-item Cross Culture Smell Identification Test (CC-SIT). Laryngoscope. 106(3 Pt 1): 353-356.
17. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorksi L, Rosenbert L. 1984. Smell identification ability: changes with age. Science. 226:1441-1443.
18. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HL. 1992. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 55:138-142.
19. Fahn S, Elton RL. 1987. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park (NJ): MacMillan Healthcare Information. p. 153-163.
20. Frigerio R, Fujishiro H, Ahn T-B, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, et al. 2009. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging. doi: 10.1001.archneurol.2009.170.
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 55:181-184.
22. Jellinger KA. 2004. Lewy body-related a-synucleinopathy in the aged human brain. J Neurol Transm. 111:1219-1235.
23. Larsson M, Finkel D, Pedersen NL. 2000. Odor identification: influences of age, gender, cognition, and personality. J Gerontol: Psychol Sci. 55B: P304-P310.
24. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, et al. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of consortium on DLB International Workshop. Neurology. 47:1113-1124.
25. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadian E. 1984. Clinical diagnosis of AD. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task Force on AD. Neurology. 34:939-944.
26. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD. 2001. Anosmia in dementia is associated with Lewy bodies rather than AD pathology. J Neurol Neurosurg Psychiatry. 70:739-743.
27. Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R. 2005. Anosmia is a very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 76:1342-1347.
28. Ponsen MM, Stoffers D, Booji J, van Eck-Smit BL, Wolters ECh, Berendse HW. 2004. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 56:173-181.
29. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, et al. 2006. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 21: 2062-2067.
30. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR. 2008. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol. 63:167-173.
31. Russell MJ, Cummings BJ, Profitt BF, Wysocki CJ, Gilbert AN, Cotman CW. 1993. Life span changes in the verbal categorization of odors. J Gerontol: Psychol Sci. 48:P49-P53.
32. Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S. 2004. Lewy body-related a-synucleinopathy in aging. J Neuropathol Exp Neurol. 63:742-749.
33. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. 2007. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 69:2197-2204.
34. Schneider JA, Li J, Li Y, Wilson RS, Kordower JH, Bennett DA. 2006. Subtantia nigra tangles are related to gait impairment in older persons. Ann Neurol. 59:166-173.
35. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ. 1996. Longitudinal changes in smell identification. J Gerontol: Med Sci. 51A:M86-M91.
36. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarach B, Stoof JC, Wolters EC. 2001. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord. 16:41-46.
37. Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. 2009. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry. 80:667-670.
38. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. 2009. Olfactory impairment in presymptomatic Alzheimer's disease. Ann NY Acad Sci. 1170:730-735.
39. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. 2007. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 78: 30-35.
40. Wilson RS, Arnold SE, Tang Y, Bennett DA. 2006. Odor identification and decline in different cognitive domains in old age. Neuroepidemiol. 26: 61-67.
41. Wilson RS, Krueger KR, Boyle PA, Bennett DA. 2010. Loss of basic lexical knowledge in old age. J Neurol Neurosurg Psychiatry. Advance Access published August 27, 2010, doi:10.1136/jnnp.2010.212589.
42. Wilson RS, Leurgans SE, Boyle PA, Bennett DA. Forthcoming. Cognitive decline in prodromal Alzheimer's disease and mild cognitive impairment. Arch Neurol.
43. Wilson RS, Leurgans SE, Boyle PA, Schneider JA, Bennett DA. 2010. Neurodegenerative basis of age-related cognitive decline. Neurology. 75: 1070-1078.
44. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. 2007. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 64:802-808.
45. Wilson RS, Schneider JA, Beckett LA, Evans DA, Bennett DA. 2002. Progression of gait disorder and rigidity and risk of death in older persons. Neurology. 58:1815-1819.
46. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. 2003. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 60:539-544.